Revvity
Tricia Ciasulli has worked in various roles and companies throughout their career. Tricia currently holds the position of VP, Enterprise Operations & Transformation at Revvity since 2023. Prior to this, they were employed at PerkinElmer, Inc. where they served as Vice President, Integration Transformation Office and BD from 2022 to 2023. Before that, they held the position of Leader, Integration Transformation Office from 2021 to 2022 and Managing Director, Strategy & Business Development from 2016 to 2021. Tricia also worked at GE Healthcare as Director, Business Development from 2014 to 2014, Business Development Manager from 2013 to 2014, and Finance Manager, Business Development from 2011 to 2012. Tricia'scareer began at Thermo Fisher Scientific Inc., where they held the roles of Associate, Strategy and Corporate Development from 2010 to 2011, Senior Analyst, Corporate Development from 2008 to 2010, and Analyst, Corporate Development from 2006 to 2008.
Tricia Ciasulli's education history includes attending the UNH Peter T. Paul College of Business and Economics, with a focus on Finance and Accounting. Prior to that, they attended Winnacunnet High School.
Revvity
8 followers
At Revvity, “impossible” is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. With more than $3 billion in revenue and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries. Learn more at www.revvity.com